DaVita Gross Margin 2010-2024 | DVA

Current and historical gross margin for DaVita (DVA) over the last 10 years. The current gross profit margin for DaVita as of March 31, 2024 is %.
DaVita Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $12.34B $4.00B 32.40%
2023-12-31 $12.14B $3.82B 31.47%
2023-09-30 $11.91B $3.64B 30.58%
2023-06-30 $11.74B $3.45B 29.40%
2023-03-31 $11.67B $3.42B 29.28%
2022-12-31 $11.61B $3.40B 29.28%
2022-09-30 $11.64B $3.46B 29.70%
2022-06-30 $11.63B $3.52B 30.30%
2022-03-31 $11.62B $3.56B 30.68%
2021-12-31 $11.62B $3.65B 31.39%
2021-09-30 $11.58B $3.61B 31.18%
2021-06-30 $11.57B $3.63B 31.41%
2021-03-31 $11.53B $3.58B 31.03%
2020-12-31 $11.55B $3.56B 30.83%
2020-09-30 $11.54B $3.61B 31.28%
2020-06-30 $11.52B $3.57B 31.00%
2020-03-31 $11.49B $3.56B 31.01%
2019-12-31 $11.39B $3.47B 30.50%
2019-09-30 $11.31B $3.37B 29.79%
2019-06-30 $11.25B $3.24B 28.80%
2019-03-31 $11.30B $3.17B 28.09%
2018-12-31 $11.40B $3.21B 28.15%
2018-09-30 $11.36B $3.26B 28.64%
2018-06-30 $11.28B $3.28B 29.11%
2018-03-31 $11.09B $3.27B 29.48%
2017-12-31 $10.88B $3.24B 29.75%
2017-09-30 $7.77B $2.60B 33.38%
2017-06-30 $8.74B $2.82B 32.21%
2017-03-31 $9.76B $3.06B 31.33%
2016-12-31 $10.71B $3.28B 30.60%
2016-09-30 $10.76B $3.27B 30.35%
2016-06-30 $10.56B $3.26B 30.86%
2016-03-31 $10.28B $3.20B 31.15%
2015-12-31 $9.98B $3.13B 31.32%
2015-09-30 $13.58B $3.90B 28.73%
2015-06-30 $13.30B $3.80B 28.57%
2015-03-31 $13.04B $3.74B 28.67%
2014-12-31 $12.80B $3.68B 28.73%
2014-09-30 $12.53B $3.65B 29.12%
2014-06-30 $12.28B $3.63B 29.55%
2014-03-31 $11.98B $3.56B 29.71%
2013-12-31 $11.77B $3.57B 30.30%
2013-09-30 $11.18B $3.40B 30.41%
2013-06-30 $10.13B $3.12B 30.76%
2013-03-31 $9.17B $2.87B 31.33%
2012-12-31 $8.19B $2.60B 31.79%
2012-09-30 $7.46B $2.42B 32.40%
2012-06-30 $7.27B $2.37B 32.54%
2012-03-31 $7.02B $2.25B 32.06%
2011-12-31 $6.73B $2.10B 31.17%
2011-09-30 $6.41B $1.85B 28.85%
2011-06-30 $6.30B $1.79B 28.35%
2011-03-31 $6.22B $1.76B 28.33%
2010-12-31 $6.22B $1.79B 28.81%
2010-09-30 $6.36B $1.93B 30.37%
2010-06-30 $6.28B $1.90B 30.30%
2010-03-31 $6.21B $1.89B 30.49%
2009-12-31 $6.10B $1.86B 30.47%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.274B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00